Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,171 recruiting studies in this area right now.
By phase
- Not applicable9,517
- Phase 24,403
- Phase 12,662
- Phase 1/Phase 21,653
- Phase 31,392
- Phase 2/Phase 3284
- Phase 4260
Top conditions
- Breast Cancer1,197
- Prostate Cancer645
- Cancer634
- Colorectal Cancer481
- Lung Cancer417
- Ovarian Cancer337
- Multiple Myeloma329
- Pancreatic Cancer290
- Gastric Cancer283
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma256
- Solid Tumor246
- Advanced Solid Tumor234
- Head and Neck Cancer225
- Cervical Cancer224
- Endometrial Cancer209
- Advanced Solid Tumors202
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University302
- National Cancer Institute (NCI)292
- Memorial Sloan Kettering Cancer Center290
- Sun Yat-sen University273
- Mayo Clinic238
- City of Hope Medical Center142
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences141
- AstraZeneca133
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,410
- Texas635
- Arizona509
- Florida435
- Alabama427
- New York404
- Massachusetts340
- Maryland330
- New Jersey271
- Pennsylvania234
Recruiting studies20,171 total
- NCT07539155RecruitingPhase 1/Phase 2
MMR Vaccine Injection for Advanced Pancreatic Cancer
This trial tests whether injecting an MMR (measles, mumps, rubella) vaccine directly into a pancreatic tumor can help your immune system fight the cancer. You're eligible if your pancreatic cancer cannot be surgically removed after standard chemotherapy and radiation treatment.
Little Rock, ArkansasAges 18 years+ - NCT07538024Recruiting
Reduced-dose radiation for spine cancer spread
This trial tests whether lower radiation doses work well for treating cancer that has spread to the spine. If you have a few spine tumors that are stable or causing symptoms, this study might help doctors find safer, faster treatment options.
Negrar, VeronaAges 18 years+ - NCT07542106Recruiting
Visual Biofeedback vs. Standard Therapy After Breast Cancer Surgery
This study compares a new visual biofeedback program (using real-time visual feedback to guide exercises) with standard physical therapy to help restore shoulder movement, strength, and function in women recovering from breast cancer surgery. The goal is to see which approach helps patients regain mobility and reduce pain more effectively.
Badajoz, BadajozAges 18 years+ - NCT07541911Recruiting
Confocal Microscopy to Check Prostate Cancer Surgery Margins
This study tests whether a special microscope can help surgeons see cancer margins (edges) during prostate removal surgery to make sure all cancer is removed. It may help surgeons make real-time decisions about how much tissue to remove.
LondonAges 18 years+ - NCT07541521Recruiting
Robot-Assisted Lung Surgery After Immunotherapy for Lung Cancer
This trial tests whether combining immunotherapy with chemotherapy before robot-assisted lung surgery improves outcomes for patients with stage II–III non-small cell lung cancer. The goal is to shrink the tumor before surgery and then remove it completely using minimally invasive robotic techniques.
Fuzhou, FujianAges Any age - NCT07542171Recruiting
Outcomes after incomplete early colon cancer removal
This study follows patients who had early colon cancer removed by endoscopy (a camera procedure) but the removal was incomplete. Researchers will track what happens when patients either have surgery afterward or are closely watched instead, to understand the best next steps.
Guangzhou, GuangdongAges 18–75 - NCT07538050Recruiting
Testing a new, affordable HPV screening method
This study tests ScreenFire, a new low-cost test for HPV (a virus linked to cervical cancer) that you can do yourself at home. Researchers want to see if it works as well as standard tests and costs less.
San Salvador, OrienteAges 30–59 - NCT07539038Recruiting
Exercise Program for Early-Stage Hormone-Positive Breast Cancer
This study tests whether a structured exercise program helps women with early-stage hormone-positive breast cancer who are taking endocrine therapy (hormone-blocking medications). The goal is to see if physical activity improves outcomes and quality of life during treatment.
Aviano, PordenoneAges 18 years+ - NCT07537205Enrolling by invitation
Nurse-led preparation program for liver cancer surgery
This study tests whether a personalized preparation program led by nurses before liver cancer surgery helps patients recover better and have fewer complications. The program is designed specifically for people scheduled to have part of their liver removed.
Shanghai, XuhuiAges 18–84 - NCT07538648RecruitingPhase 1
Imaging Dye for Surgery to Find Solid Tumors
This study tests a new injectable dye (NC527-X) that helps surgeons see tumors better during surgery. The dye glows under special light, making it easier to find and remove cancer tissue completely.
Hangzhou, ZhejiangAges 18 years+ - NCT07540026Recruiting
Comparing Two Treatments for Bleeding Stomach Tumors
This trial tests two medications—tranexamic acid and sucralfate—applied during an endoscopy (a camera procedure) to stop bleeding caused by tumors in the upper digestive tract. The goal is to see which treatment works better at controlling the bleeding.
Tainan, Not Required For This CountryAges 18 years+ - NCT07534033RecruitingPhase 2
Probiotic LR607 for newly diagnosed lung cancer
This study tests whether a probiotic supplement (LR607) can help patients with newly diagnosed non-small cell lung cancer—a common type of lung cancer. Probiotics are beneficial bacteria that may help your immune system fight cancer alongside standard treatments.
GuangzhouAges 18–80 - NCT07534852Recruiting
Nutrition and exercise support for colon cancer surgery patients
This study tests whether nutrition support and exercise help patients with early-stage colon cancer recover better after surgery. Researchers will provide dietary guidance and a supervised exercise program tailored to your needs.
Málaga, MalagaAges 18–75 - NCT07540260Recruiting
Imaging-Guided Radiation Therapy for Advanced Kidney Cancer
This trial uses two types of PET scans to better target radiation therapy in patients with advanced clear cell kidney cancer that has spread or returned. The goal is to combine radiation with standard drug treatments to improve outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07542262Enrolling by invitationPhase 2
Low-dose immunotherapy for advanced colorectal and stomach cancer
This study tests a lower dose of immunotherapy in patients with colorectal or stomach cancer that has spread or cannot be removed by surgery. The cancer must have a specific genetic feature (MSI/dMMR). The goal is to see if this approach works well with fewer side effects.
MoscowAges 18 years+ - NCT07539441RecruitingPhase 1/Phase 2
Mirdametinib for brain and nervous system tumors
This trial tests a drug called mirdametinib for people with specific types of brain tumors or neurohistiocytosis (a rare condition affecting the nervous system). The drug targets mutations that cause these conditions to grow.
Basking Ridge, New JerseyAges 18 years+ - NCT07535541Recruiting
Smartwatch Study of Hot Flashes in Prostate Cancer Patients
This study tests whether a smartwatch can accurately measure hot flashes (sudden heat and sweating) that occur in men undergoing hormone therapy for prostate cancer. You'll wear the smartwatch for about 4 weeks while the research team tracks your symptoms.
Charlottesville, VirginiaAges 18 years+ - NCT07541365Recruiting
Wearable Sensors to Track Health in Cancer Trials
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
Cleveland, OhioAges 18 years+ - NCT07540650RecruitingPhase 2
Preventive radiation to reduce bone complications in metastatic cancer
This trial tests whether giving radiation therapy to spots where cancer has spread to the bone can prevent future bone problems like fractures. It's for people who have a few bone metastases that aren't causing severe pain yet.
LjubljanaAges 18 years+ - NCT07537010RecruitingPhase 1
3D1015 Injection for Advanced Prostate Cancer
This Phase 1 trial tests a new injectable treatment called 3D1015 for men with advanced prostate cancer that has spread and stopped responding to hormone therapy. The drug is designed to target cancer cells using a special imaging marker that shows up on PET scans.
Wuxi, JiangsuAges 18 years+ - NCT07538947Recruiting
Real-time imaging to diagnose lung cancer faster and safer
This trial tests a new camera tool (confocal laser endomicroscopy) that lets doctors see lung tissue in real-time during a biopsy procedure. The goal is to diagnose non-small cell lung cancer more quickly and safely than standard biopsies alone.
NancyAges 18 years+ - NCT07538882Recruiting
AI-Assisted Staging and Treatment Planning for Liver Cancer
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
Beijing, ChangpingAges 18 years+ - NCT07540403Recruiting
Study of ovarian cancer outcomes in treatment-resistant cases
This research study follows patients with epithelial ovarian cancer that has returned or worsened quickly after treatment (within 6 months). The goal is to understand survival patterns and outcomes in these difficult-to-treat cases to potentially improve future care.
RomeAges 18 years+ - NCT07538635RecruitingPhase 2
CAR-T cells plus stem cell transplant for aggressive lymphoma
This trial tests a two-step treatment for patients with an aggressive type of blood cancer (large B-cell lymphoma) that has come back or didn't respond well to standard therapy. You'll receive a stem cell transplant followed by CAR-T cells—specially engineered immune cells designed to fight cancer.
Hangzhou, ZhengjiangAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,171 recruiting oncology studies from the U.S. registry right now, out of 30,126 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.